Elanco Animal Health Inc (ELAN)

Jun 5, 2025, 7:45 AM EDT - 15 hours ago

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

May 28, 2025, 7:25 AM EDT - 8 days ago

Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

May 16, 2025, 8:00 AM EDT - 20 days ago

Elanco to Participate in the Upcoming Investor Conferences

May 12, 2025, 4:26 AM EDT - 24 days ago

Elanco: Deleveraging Takes Time

May 7, 2025, 12:52 PM EDT - 4 weeks ago

Elanco Animal Health Incorporated (ELAN) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:03 AM EDT - 4 weeks ago

Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide

May 7, 2025, 6:27 AM EDT - 4 weeks ago

Elanco Animal Health Reports First Quarter 2025 Results

May 6, 2025, 10:00 AM EDT - 4 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect

May 5, 2025, 4:40 PM EDT - 4 weeks ago

Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal

BX

May 5, 2025, 6:27 AM EDT - 4 weeks ago

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

TARS

May 4, 2025, 10:00 AM EDT - 4 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out

May 1, 2025, 10:00 AM EDT - 5 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation

Apr 29, 2025, 10:00 AM EDT - 5 weeks ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 24, 2025, 10:00 AM EDT - 6 weeks ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 23, 2025, 1:16 PM EDT - 6 weeks ago

Trade Tracker: Sarat Sethi buys Zoetis and sells Elanco

ZTS

Apr 22, 2025, 10:00 AM EDT - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect

Apr 22, 2025, 8:27 AM EDT - 6 weeks ago

Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day

Apr 20, 2025, 10:00 AM EDT - 6 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation

Apr 17, 2025, 10:00 AM EDT - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation

Apr 15, 2025, 10:00 AM EDT - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect

Apr 13, 2025, 10:00 AM EDT - 7 weeks ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation

Apr 10, 2025, 8:00 AM EDT - 2 months ago

Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement

Apr 8, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Investors to Inquire about Securities Investigation

Apr 6, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Reach Out

Mar 30, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation

Mar 17, 2025, 4:17 PM EDT - 2 months ago

Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets

Mar 4, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Reach Out

Feb 25, 2025, 1:38 PM EST - 3 months ago

Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff

Feb 25, 2025, 10:59 AM EST - 3 months ago

Elanco Animal Health Incorporated (ELAN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 7:05 AM EST - 3 months ago

Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle

Feb 25, 2025, 7:05 AM EST - 3 months ago

Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results

Feb 21, 2025, 8:00 AM EST - 3 months ago

Elanco to Participate in Upcoming Investor Conferences

Feb 20, 2025, 8:27 AM EST - 3 months ago

Elanco Launches Pet Protect™ From the Makers of Advantage®: Veterinarian-Formulated Supplements for Complete Pet Wellness

Feb 13, 2025, 4:29 PM EST - 4 months ago

Elanco Reinforces Commitment to Veterinary and Pet Owner Education

Feb 4, 2025, 8:00 AM EST - 4 months ago

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement

Jan 27, 2025, 8:06 AM EST - 4 months ago

Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal

Jan 15, 2025, 6:42 AM EST - 5 months ago

Elanco Animal Health: Building On Success

Dec 19, 2024, 11:07 AM EST - 6 months ago

Elanco to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 6, 2024, 11:51 AM EST - 6 months ago

ELAN Deadline Today: Rosen Law Firm Urges Elanco Animal Health Incorporated (NYSE: ELAN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Dec 6, 2024, 12:20 AM EST - 6 months ago

ELAN Deadline: ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit

Dec 5, 2024, 10:15 AM EST - 6 months ago

DEADLINE APPROACHING: The Schall Law Firm Encourages Shareholder Contributions To A Fraud Case Against Elanco Animal Health Incorporated

Dec 4, 2024, 3:45 PM EST - 6 months ago

Elanco Animal Health Incorporated Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Join The Schall Law Firm